The expression of E2F7 was further detected in fresh glioma tissues by IHC and qRT−PCR; we found that E2F7 was also abnormally amplified in fresh glioblastoma tissues (Fig. 1c, d). This evidence concerns the gene E2F7 and central nervous system cancer.